Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
大麻二酚(Epidyolex®)用于治疗结节性硬化症、III型粘多糖贮积症和脆性X综合征患者的严重行为表现:一系列随机、安慰剂对照的N-of-1试验方案
期刊:BMC Psychiatry
影响因子:3.6
doi:10.1186/s12888-023-05422-3
Müller, A R; den Hollander, B; van de Ven, P M; Roes, K C B; Geertjens, L; Bruining, H; van Karnebeek, C D M; Jansen, F E; de Wit, M C Y; Ten Hoopen, L W; Rietman, A B; Dierckx, B; Wijburg, F A; Boot, E; Brands, M M G; van Eeghen, A M